Keywords
Epidemiology
Signs and symptoms
Public health
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the clinical profile of leprosy in the territory of Teresina, in the state of Piauí and in Brazil, from 2013 to 2022. Methods: This is an epidemiological, quantitative, population-based study on the analysis of leprosy cases. The data search was carried out through the Notifiable Diseases Information System - SINAN. Results: 328,356 cases of leprosy were reported in Brazil, 32,835.6 cases/year. Of these, around 140,541 were registered in the Northeast Region, with 11,585 cases reported in Piauí, with 1,158.5 annual notifications and 4,410 occurrences in the city of Teresina, with 441 cases per year. It was found that the Dimorpha clinical form was predominant in Brazil, with 158,238 (48.2%) occurrences, followed by the Virchowian form (18.0%). In Piauí, the majority of leprosy cases were classified as Dimorphous, 5,006 (43.2%) cases, and undetermined, 1,896 (16.4%) occurrences. In Teresina, the Dimorpha forms (48.4%) and Virchowiana (16.2%) also stood out. Conclusion: Regarding the clinical profile of the disease, the main form of clinical presentation is Dimorpha, both in Brazil, Piauí and Teresina. These data can contribute to understanding Leprosy in the country, and direct health promotion, prevention and rehabilitation actions.
References
ANJOS LHG, et al. Perfil epidemiológico da Hanseníase no estado do Maranhão de 2018 a 2020. Pesquisa, Sociedade e Desenvolvimento, 2021; 15: 272101523156.
ARAÚJO OD, et al. Mortalidade relacionada à hanseníase no Estado do Piauí, Brasil: tendências temporais e padrões espaciais, 2000-2015. Cadernos de Saúde Pública [online], 2020; 36(9): 00093919.
AZEVEDO YP, et al. Perfil epidemiológico e distribuição espacial da hanseníase em Paulo Afonso, Bahia. Rev baiana enferm, 2021; 35: 1-11.
BATISTA JVF. et al. Características epidemiológicas da hanseníase no Brasil entre os anos de 2015 e 2020. The Brazilian Journal of Infectious Diseases, 2022; 26: 102089.
BRASIL. Guia prático sobre a hanseníase. Brasília. 2017. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/guia_pratico_hanseniase.pdf . Acessado em 12/12/23.
BRASIL, Ministério da Saúde. Secretaria de Vigilância em Saúde, Ministério da Saúde. Caracterização da situação epidemiológica da hanseníase e diferenças por sexo, Brasil, 2012-2016. Boletim Epidemiológico 2018; 49:1-12.
CASTILLO RR, et al. Leprosy in children in Cuba: epidemiological and clinical description of 50 cases from 2012-2019. PLoS Negl Trop Dis. 2021; 15(10): 0009910.
CHEN KH, et al. Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management. Journal of Tropical Medicine, 2022; 8652062: 1-13.
CUNHA DV, et al. Perfil Epidemiológico da Hanseníase no Município de Castanhal –Pará no período de 2014 a 2017. Revista Eletrônica Acervo Saúde, 2019; 11(15): 1-8.
FIRMO JA, et al. Perfil epidemiológico da hanseníase no município de Lavras da Mangabeira, estado do Ceará, Brasil, nos anos de 2011 a 2020. Revista Eletrônica Acervo Saúde, 2023; 23(5): 12424.
FONSECA AB, et al. The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy. Infect Dis Poverty, 2017; 6(5).
FREITAS BHBM, et al. Leprosy educational practices with adolescents: an integrative literature review. Rev Bras Enferm, 2019; 72(5): 1397-1404.
LANZA FM, et al. Perfil epidemiológico da hanseníase no município de Divinópolis, Minas Gerais, 2011 a 2019. Medicina (Ribeirão Preto) [Internet]. 2022; 55(3): 193699.
LIRA TB, et al. Hanseníase no Piauí: uma investigação epidemiológica. Revista Eletrônica Acervo Saúde, 2019; 24: 499.
LOPES FS, et al. Hanseníase no contexto da Estratégia Saúde da Família em cenário endêmico do Maranhão: prevalência e fatores associados. Ciênc. saúde coletiva. São Paulo, 2021; 26(5): 1-12.
MALHOTRA KP, HUSAIN N. Laboratory perspectives for Leprosy: Diagnostic, prognostic and predictive tools. Indian J Pathol Microbiol, 2022; 65: S300-S309.
MAXIMIANO HRL, et al. Perfil epidemiológico da Hanseníase na microrregião da planície litorânea do Piauí: Epidemiological profile of Leprosy in the micro-region of the coastal coast of Piauí. Brazilian Journal of Development, 2022;8(8):59264–59278.
MAYMONE MBCM, et al. “Leprosy: clinical aspects and diagnostic techniques,” Journal of the American Academy of Dermatology, 2020; 83(1): 1–14.
NIITSUMA ENA, et al. Fatores associados ao adoecimento por hanseníase em contatos: revisão sistemática e metanálise. Rev. bras. Epidemiol, 2021; 24: e210039.
NOVATO KM, et al. Perfil epidemiológico da hanseníase no estado do Tocantins no período DE 2014 A 2016. Revista De Patologia Do Tocantins, 2020; 6(4): 5.
NUNES OS, et al. Perfil clínico e epidemiológico dos casos de hanseníase em menores de 15 anos em um município da região metropolitana de Goiânia, Goiás. Revista Eletrônica Acervo Saúde, 2019; 17.
OLIVEIRA LO, et al. Perfil Epidemiológico da Hanseníase na Bahia no Período de 2010 a 2020. Pesquisa, Sociedade e Desenvolvimento, [S. l.], 2022; 4: 16911427228.
PIMENTEL, Maria Inês Fenandes et al. Influência do tempo de evolução prévio ao diagnóstico inicial incapacidades presentes no exame inicial de pacientes portadores de hanseníase multibacilar. Hansenologia Internationalis: hanseníase e outras doenças infecciosas, 2002; 27(2): 77-82.
PESCARINI JM, et al. Socioeconomic risk markers of leprosy in high-burden countries: a systematic review and meta-analysis. PLoS Negl Trop Dis, 2018; 12(7).
RAO, PSS SUNDAR. Current epidemiology of leprosy in India. Leprosy review, 2006; 77(4): 292-294.
SÁ SC, SILVA DS. Perfil epidemiológico da hanseníase em um município da região norte do Brasil. Brazilian Journal of Development, 2021; 7(1): 8959-8974.
SALGADO CG, et al. Are leprosy case numbers reliable? Lancet Infect Dis., 2018; 18: 135-137.
SANTOS KCB, et al. Estratégias de controle e vigilância de contatos de hanseníase: revisão integrativa. Saúde debate, 2019; 43(121).
SARODE G, et al. Epidemiological aspects of leprosy. Dis Mon, 2020; 66(7): 100899.
SASIDHARANPILLAI S, et al. Role of histopathology in predicting type 1 lepra reaction in borderline tuberculoid leprosy,” Indian Dermatology Online Journal, 2020; 11(4): 586.
SILVA LSR, et al. Perfil clínico e epidemiológico dos casos de hanseníase em pacientes adultos em um município do Maranhão. Revista Eletrônica Acervo Saúde, 2020; 12(9): 1-8.
SOUZA CDF, et al. Leprosy in Brazil in the 21st century: analysis of epidemiological and operational indicators using inflection point regression. An Bras Dermatol. 2020; 95: 743–7.
SOUZA CD, et al. Trend of leprosy detection rate in Brazil, 1990 to 2016. An Bras Dermatol. 2019; 94: 603–7.
TAVARES AMR. Epidemiological profile of leprosy in the state of Mato Grosso: descriptive study. einstein (São Paulo) [Internet]. 2021; 19: AO5622.
TIWARI A, et al. Leprosy post-exposure prophylaxis in the Indian health system: a cost-effectiveness analysis. PLoS Neglected Tropical Diseases, 2020; 14(8).
VENKATAKRISHNAN Y, et al. Nutritional status and morbidity profile of children with leprosy contact in a rural community. Trop Doct 2020; 50(4): 311-7.
WHO. World Health Organization. Regional Office for South-East Asia. Guidelines for the diagnosis, treatment and prevention of leprosy. World Health Organization. Regional Office for South-East Asia, 2022.
WHO. Word Health Organization.Towards zero leprosy Global Leprosy (Hansen’s disease) Strategy 2021-2030. 2021.
WHO. Word Health Organization. Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. Weekly Epidemiological Record, 2020; 95: 417-440.
WHO. World Health Organization. Global leprosy update, 2017: reducing the disease burden due to leprosy. 2017; 93: 445‐56.